Ecovyst transformed its business by selling its Advanced Materials & Catalysts segment at a strong valuation and using the proceeds to reduce debt and acquire Calabrian, enhancing its sulfur chemistry platform. This strategic shift helped drive a 42% increase in sales and a 26.7% rise in adjusted EBITDA in Q2 2026, supported by volume growth, pricing strategies, and asset integration. The company’s focus on recurring revenues, long-term contracts, and regional logistics barriers positions it as essential process infrastructure rather than a commodity chemical producer. Investors may see valuation gains as cash flow improves and leverage decreases following the Calabrian acquisition.
Eli Lilly became the first pharmaceutical company valued over $1 trillion, driven by strong revenue growth and promising drugs like retatrutide and orforglipron. The company reported a 47.67% revenue increase in Q2 and raised its 2026 revenue guidanc...
Hermes reported accelerating revenue growth and a 41% operating margin in Q2 despite challenges in the luxury sector. The stock trades at about 35 times earnings, a 20% discount to its 15-year average, with analysts expecting a 17-20% price increase....
Lumentum has been upgraded to a Buy rating due to rapidly accelerating demand for AI-driven optical networking. The adoption of new technologies like NPO and CPO is boosting Lumentum's revenue and margins, with expectations that revenue will more tha...
SK Hynix's stock rose 6% following approval of a $28.6 billion treasury share repurchase and cancellation, the largest in South Korean history. This move boosts investor confidence amid ongoing debates about the sustainability of the AI-driven memory...
Midstream pipeline funds like AMLP, MLPX, and ENFR are gaining attention as hyperscalers sign long-term power deals fueling AI data centers, boosting natural gas demand. AMLP offers the highest yield near 8% but has a C-corp tax drag, while MLPX bala...
